Clinical Trial Update: Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma [Phase 2]

View source ↗

Summary

This Clinical Trials update notes a Phase II neoadjuvant trial combining thymosin alpha-1, a PD-1 inhibitor, and chemoradiotherapy for stage III gastroesophagea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• PD-1 inhibitor
• Thymalfasin (thymosin alpha-1)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Gastric Cancer | Phase 2 | Status: RECRUITING